Psyence Biomedical
11 hedge funds and large institutions have $201K invested in Psyence Biomedical in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
38% more funds holding
Funds holding: 8 → 11 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
28% less capital invested
Capital invested by funds: $280K → $201K (-$79K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$279K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$60.9K |
| 3 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
+$29.8K |
| 4 |
Jane Street
New York
|
+$16.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
-$6K |
| 2 |
VF
Virtu Financial
New York
|
-$4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.71K |
| 4 |
HT
Headlands Technologies
Chicago,
Illinois
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $123K | +$279K | +206 | +166% |
|
|
CF
2
Cantor Fitzgerald
New York
| $33.7K | – | – | – |
|
|
3
Citadel Advisors
Miami,
Florida
| $16.9K | +$60.9K | +45 | New |
|
|
SFFS
4
Stonehage Fleming Financial Services
St. Helier,
Jersey
| $8.05K | +$29.8K | +22 | New |
|
5
Morgan Stanley
New York
| $4.84K | +$10.8K | +8 | +160% |
|
|
6
Jane Street
New York
| $4.6K | +$16.2K | +12 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3.44K | +$12.2K | +9 | New |
|
|
HF
8
HRT Financial
New York
| $2K | +$2.71K | +2 | +40% |
|
|
9
UBS Group
Zurich,
Switzerland
| $1.5K | -$2.71K | -2 | -33% |
|
|
TSS
10
Two Sigma Securities
New York
| $1.5K | +$5.41K | +4 | New |
|
11
Geode Capital Management
Boston,
Massachusetts
| $1.05K | – | – | – |
|
|
CS
12
Clear Street
New York
| – | -$6K | -5 | Closed |
|
|
VF
13
Virtu Financial
New York
| – | -$4K | -4 | Closed |
|
|
HT
14
Headlands Technologies
Chicago,
Illinois
| – | -$8 | – | – |
|
PBM Hedge Fund Activity: Q3 2024 in Review
11 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical (PBM) for Q3 2024, worth a combined $201K — down 28% from $280K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PBM positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was AdvisorShares Investments, adding an estimated $279K. The largest seller was Clear Street, exiting entirely with an estimated $6K sold.
- 11 institutional investors held Psyence Biomedical (PBM) as of Q3 2024, up from 8 in Q2 2024.
- Funds reported $201K of Psyence Biomedical stock for Q3 2024, down 28% quarter-over-quarter.
- 5 funds opened new Psyence Biomedical positions in Q3 2024 and 2 closed out, a net change of +3 holders.
- The largest Psyence Biomedical buyer in Q3 2024 was AdvisorShares Investments, an estimated $279K added.
- The largest Psyence Biomedical seller in Q3 2024 was Clear Street, an estimated $6K sold.
Based on aggregated 13F filings for Q3 2024.